| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 12/30/2004 | US20040266665 Therapy for thyroid disease; anticancer agents; metabolitic and reproductive diseases |
| 12/30/2004 | US20040266010 Modifying fatty acid content of bacterial cells to enhance gene transferability after long term storage at low temperatures |
| 12/30/2004 | US20040266009 Morphological mutants of filamentous fungi |
| 12/30/2004 | US20040266007 Modified viral particle for use in expression, isolation and purification of immmoglobulins |
| 12/30/2004 | US20040266006 Adenoviral vectors having a protein IX deletion |
| 12/30/2004 | US20040266005 Synthetic genes and genetic constructs |
| 12/30/2004 | US20040266004 Method of promoting nucleic acid transfer |
| 12/30/2004 | US20040266003 Using bacterial small membrane vessicles as tools for transfer of heterologous nucleotide sequences into cells |
| 12/30/2004 | US20040265999 Use of antisense oligonucleotides to inhibit the expression of human Akt-1 |
| 12/30/2004 | US20040265986 Method for the recovery and purification of poxviruses from infected cells |
| 12/30/2004 | US20040265981 A cDna clone; culturing liver cell in coditioning media |
| 12/30/2004 | US20040265980 Use of POX4 promoter to increase gene expression in Candida tropicalis |
| 12/30/2004 | US20040265978 Alcohol dehydrogenases from Lactobacillus |
| 12/30/2004 | US20040265975 Method for producing catalytic antibodies (variants), antigens for immunisation and nucleotide sequence |
| 12/30/2004 | US20040265974 Human chemokine polypeptides |
| 12/30/2004 | US20040265972 Modified human chorionic gonadotropin (CG) for use in treatment and prevention of metabolic and reproductive diseases |
| 12/30/2004 | US20040265969 Reverse polymerases; kits; electrophoresis |
| 12/30/2004 | US20040265968 Tissue plasminogen activator-like protease |
| 12/30/2004 | US20040265967 14790, a novel protein kinase molecule and uses therefor |
| 12/30/2004 | US20040265965 Glycosylation variants of BACE |
| 12/30/2004 | US20040265962 Staphylococcus aureus genes & polypeptides |
| 12/30/2004 | US20040265959 Highly productive alpha-amylases |
| 12/30/2004 | US20040265958 that hydrolyzes fatty amides such as cis-9,10-octadecenoamide to neutralize the soporific activity of the fatty amides; enzyme inhibitors for use in treating sleep disorders |
| 12/30/2004 | US20040265956 Using transgenic escherichia comprising expression coding factor for inversion stimulation (FIS) for use in fermentation of lysine for use in preparation of cosmetic, medicines and animal feeds |
| 12/30/2004 | US20040265955 Compositions and methods for generating multiple polypeptides from a single vector using a virus derived peptide cleavage site, and uses thereof |
| 12/30/2004 | US20040265954 Transgenic escherichia for use in the expression and propagation of N-glycosylated target proteins; bioreactors and heterologous protein expression |
| 12/30/2004 | US20040265953 Production and use of inducible enzymes from trichoderma and bacteria for control of plant pests and for industrial processes |
| 12/30/2004 | US20040265936 In gram-negative host cells; immunogenic epitopes from herpes virus; cytokines; interleukins; interferons; tumour necrosis factors; solid phase synthesis; homologous recombination |
| 12/30/2004 | US20040265934 Peptide nucleic acids; tuberculosis diagnosis; site-directed mutagenesis; kits; solid phase synthesis |
| 12/30/2004 | US20040265933 From Streptococcus pneumoniae; antigens, immunogens; shuttle vectors; vaccines; drug screening |
| 12/30/2004 | US20040265932 Detecting mRNA which translates into mammaglobin and mucin-like proteins, then detecting cDNA; isolated from Bacillus substilis; solid phase synthesis |
| 12/30/2004 | US20040265920 Sampling cerebrospinal fluid for antibodies; solid phase synthesis; immunoassay |
| 12/30/2004 | US20040265913 Tumor necrosis factors (TNF); humanized/chimeric monoclonal antibodies; fab fragments; hybridomas, host cells, Chinese Hamster Ovary cells |
| 12/30/2004 | US20040265912 Structure based and combinatorially selected oligonucleoside phosphorothioate and phosphorodithioate aptamer targeting AP-1 transcription factors |
| 12/30/2004 | US20040265908 use of purified metal binding protein, metallothionein from a brine shrimp (Artemia), to reduce the concentration of a metal in a substrate; bioremediation; pollution control |
| 12/30/2004 | US20040265900 T cells specific for target antigens and methods and vaccines based thereon |
| 12/30/2004 | US20040265898 C-type lectin transmembrane antigen expressed in human prostate cancer and uses thereof |
| 12/30/2004 | US20040265896 pharmacogenetics; determining if patient has said variant which causes sensitivity to ivermectin and other drugs that serve as P-glycoprotein substrates; canine cell used for studying effect of various drugs |
| 12/30/2004 | US20040265891 use in diagnosis and treatment of cancer, neurodegenerative, or immune disorders; antibodies for immunoassays; drug screening |
| 12/30/2004 | US20040265890 a polypeptide of given amino acid sequence; use as drug target for gastrointestinal disorders; fusion proteins; diagnosis |
| 12/30/2004 | US20040265888 Binary encoded sequence tags |
| 12/30/2004 | US20040265887 predicting a clinical response to treatment with a chemotherapeutic agent by determining the activity of a gene encoding a DNA repair enzyme |
| 12/30/2004 | US20040265885 Peptide nucleic acid (PNA) derivatives which carry one or more phosphoryl radicals at the N terminus of the PNA backbone; can be purified using efficient methods such as chromatography or electrophoresis; use as pharmaceuticals and diagnostic agents |
| 12/30/2004 | US20040265879 peptide nucleic acid conjugate of a nucleic acid analog covalently linked to a peptide transporter moiety; enhance antisense activity; drug delivery; conjugate is a morpholino-base with phosphorodiamidate linkages with a peptide such as Arg9Phe2 (arginine9phenylalanine2) |
| 12/30/2004 | US20040265878 Polypeptides and polynucleotides "BASB040" from neisseria meningitidis and vaccine comprising said polypeptides and polynucleotides |
| 12/30/2004 | US20040265875 Prokaryotic glycosyltransferases, sialyltransferases, galactosyltransferases, and other enzymes involved with production of lipooligosaccharides |
| 12/30/2004 | US20040265872 nucleotide sequences for polypeptides of the riboflavin specific deaminase family, "ribG"; drug target for use screening for antibacterials; vectors, host cells |
| 12/30/2004 | US20040265866 Receptor on the surface of activated T-cells: ACT-4 |
| 12/30/2004 | US20040265865 Method for identifying effector molecules |
| 12/30/2004 | US20040265864 removing erythrocytes and blood components other than leukocytes from the whole blood by filtration, then lysing leukocytes of the whole blood, and quantifying the specific mRNA in the lysate; leukocyte filters attached to oligo(dT)-immobilized multi-well plates; use in diagnosis, blood bank screening |
| 12/30/2004 | US20040265863 Nucleotide sequences coding topoisomerase binding sites for use in vector which permit the simultaneous cloning of two or more different nucleic acid molecules; host cells and kits |
| 12/30/2004 | US20040265862 Screening method for genes of brewing yeast |
| 12/30/2004 | US20040265861 Materials and methods for identifying genes and/or agents that alter replicative lifespan |
| 12/30/2004 | US20040265860 Production of proteins using homologous recombination |
| 12/30/2004 | US20040265858 Sets of generalized target-binding e-tag probes |
| 12/30/2004 | US20040265857 Cloning gene or fragment thereof via hybridization probe; solid phase synthesis; plasmids; for treating mycosis |
| 12/30/2004 | US20040265856 5' portion of an intestinal lactase-phlorizine hydrolase (LPH) gene; point mutations; solid phase synthesis; immunoassay; vectors; primers; host cells; antibodies; kits; gene therapy |
| 12/30/2004 | US20040265855 Automatically sampling cells, lysing, separating cell debris/endotoxins, transfecting, then screening libraries via robots (which comprise computers, microtitre plates, and conveyors); solid phase synthesis |
| 12/30/2004 | US20040265851 Polymerase chain reaction to quantify pyrophosphoric acid production; analyzing actin and/or glyceraldehyde 3-phosphate dehydrogenase levels |
| 12/30/2004 | US20040265848 Circovirus sequences associated with piglet weight loss disease (PWD) |
| 12/30/2004 | US20040265841 Analyzing mutations in Myosin Light Chain 2a; titin-related diseases; drug screening; animal models; knockout cells; transgenic zebrafish; antibodies |
| 12/30/2004 | US20040265839 Gene knockout; gene overexpression; liposomes; fusion proteins; immunoglobulins; FC fragments; glutathione S-transferase (GST) polypeptides |
| 12/30/2004 | US20040265837 As well as Paget's disease, neurological/neuromuscular diseases, nerve diseases, and/or psychotropic diseases; chloride channel modulators |
| 12/30/2004 | US20040265836 Methods for the identification of inhibitors of C4 Long Chain Base Hydroxylase activity in plants |
| 12/30/2004 | US20040265835 Fluorescence activated cell-sorting; liposomes; phospholipid mimics |
| 12/30/2004 | US20040265828 Glucose dehydrogenase |
| 12/30/2004 | US20040265824 Secreted and cell surface genes expressed in benign and malignant colorectal tumors |
| 12/30/2004 | US20040265822 Method of detecting, identifying and counting enteritis vibrio using gene (rpod) sequences encoding rna polymerase sigma 70 factor |
| 12/30/2004 | US20040265821 Rna amplication system using plant components in animal cells |
| 12/30/2004 | US20040265819 Uricosuric regulating action using protein comprising an amino acid sequence represented by SEQ ID NO:1 or an amino acid sequence derived therefrom being capable of transporting uric acid and its analogs; cardiovascular disorders; gout; hypotensive agents; nucleotide sequences; antibodies; modulators |
| 12/30/2004 | US20040265818 Histidine phosphatase interacting protein with 180kd |
| 12/30/2004 | US20040265815 Method for determination of telomere length |
| 12/30/2004 | US20040265809 Polypeptides derived from retinoic acid-related orphan receptor(ror) and their applications |
| 12/30/2004 | US20040265807 Enzymes |
| 12/30/2004 | US20040265806 Position-independent and tissue specific expression of a transgene in milk of transgenic animals |
| 12/30/2004 | US20040265805 Method for cloning large DNA |
| 12/30/2004 | US20040265804 Method for identifying metastatic tumor cells |
| 12/30/2004 | US20040265803 for the prevention, diagnosis and/or therapy of MSI+ tumors; antibodies against the gene product; use as antitumor agents or vaccines |
| 12/30/2004 | US20040265801 Immunoassays for anti-HCV antibodies |
| 12/30/2004 | US20040265798 expression cassettes including nucleic acid elements for enhancing the titer of pseudotyped viral particles; heterologous envelope glycoprotein derived from a Jaagsiekte sheep retrovirus (JSRV env); use in gene therapy |
| 12/30/2004 | US20040265794 Genotyping kit for diagnosis of human papilloma virus infection |
| 12/30/2004 | US20040265791 Mammalian two-hybrid system for screening for modulators of the accumulation of metabolic products |
| 12/30/2004 | US20040265787 Immortalized human keratinocyte cell line |
| 12/30/2004 | US20040265786 Method and formulation for lyophilizing cultured human cells to preserve RNA and DNA contained in cells for use in molecular biology experiments |
| 12/30/2004 | US20040265442 Treatment of fruits or vegetables with hypersensitive response elicitor to inhibit postharvest disease or desiccation |
| 12/30/2004 | US20040265338 Contain large deletions; vaccines against dengue virus infection; structural proteins encapsulate said subgenomic replicon |
| 12/30/2004 | US20040265336 Multivalent vaccination using recombinant adenovirus |
| 12/30/2004 | US20040265332 BASB029 polynucleotide(s) and polypeptides from Neisseria meningitidis |
| 12/30/2004 | US20040265331 BASB027 proteins and genes from moraxella catarrhalis, antigens, antibodies, and uses |
| 12/30/2004 | US20040265330 Novel compounds |
| 12/30/2004 | US20040265328 Identifying polypeptide antigens that bind to sera raised against commensal bacterial proteins |
| 12/30/2004 | US20040265325 Human cytomegalovirus antigens expressed in MVA and methods of use |
| 12/30/2004 | US20040265324 Recombinant MVA virus expressing dengue virus antigens, and the use thereof in vaccines |
| 12/30/2004 | US20040265321 A dimeric fusion protein having two identical polypeptide chains, each chain wtih an extracellular region of an activating Fc gamma R containing an Fc binding site, joined to a molecule that binds an Fc gamma Rn; dimeric fusion protein specifically binds an immune complex |
| 12/30/2004 | US20040265320 Administering a compound selected from 3-O-(3',3'-dimethylsuccinyl) betulinic acid, 3-O-(3',3'-dimethylsuccinyl) betulin, 3-O-(3',3'-dimethylglutaryl) betulin, 3-O-(3',3'-dimethylsuccinyl) dihydrobetulinic acid, 3-O-(3',3'-dimethylglutaryl) betulinic acid, (3',3'-dimethylglutaryl) dihydrobetulinic acid |
| 12/30/2004 | US20040265317 Methods and compositions useful for inhibition of angiogenesis |
| 12/30/2004 | US20040265316 An antibody which specifically binds to a Fhit (fragile histidine triad) protein or derivative |
| 12/30/2004 | US20040265310 Novel prostate-restricted gene expressed in prostate cancer |
| 12/30/2004 | US20040265308 Prevention and treatment of amyloidogenic disease |
| 12/30/2004 | US20040265307 Anti-IGF-I receptor antibody |